India’s Drug Regulatory Reforms: Building Trust
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…
Address: Genome Valley ShameerpetHyderabad – 500 078 AP India
Tel: +91 40 2348 0567
Web: http://www.bharatbiotech.com/
(BBIL/Bharat Biotech), Hyderabad, India, is a multidimensional biotechnology company specialising in product-oriented research, development and manufacturing of vaccines and biotherapeutics. Bharat Biotech, established in the year 1996 by Dr. Krishna M. Ella & Mrs. Suchitra K. Ella as the Founder Directors, is engaged in developing next-generation vaccines and bio-therapeutics through innovative and collaborative research.
BBIL’s state-of-the-art manufacturing plant is the largest of its kind in Asia-Pacific. The first bio-pharma facility in the country to be audited and approved by Korean Food & Drugs Administration (KFDA), it sprawls over a picturesque campus at Genome Valley, Hyderabad. Built with an investment of over INR 1000 million, the facility’s Manufacturing, Control Procedures and Protocols, conform to the stringent standards laid down by internationally recognized institutions such as USFDA, UKMCA and WHO.
Bharat Biotech has set new benchmarks in Innovation and Quality that epitomizes the tremendous progress of Indian biotechnology in the global arena.
Our business strategy is to research, develop, manufacture and market products that have a broad market scope. It also means of achieving Pioneering research. Healthy tomorrow. We build value by the skilled management of pre-clinical and clinical development, steering the process efficiently to the completion of clinical studies that demonstrate safety and efficacy.
-IMMUTIKA Vaccine Division
-RENOVA Bio-therapeutics Division
-PrefeRx Women Health Care Division
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…
Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe,…
Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming…
In a context where even well-established, multi-billion-dollar domestic companies have received warning letters…
One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance.…
Bhupendra Sangani, founder and managing director of Galentic, one of India’s expert manufacturers of sterile and…
Dr. Satyanarayana Chava, founder and CEO of Laurus Labs, provides insights into the distinctive model that has…
Luca Visini, the recently appointed managing director of Eli Lilly & Company for India, shares with us his…
Dr. Letitia Robinson, Director of the US FDA India Office, provides insights into the main goals and…
Dr. Deepak Birewar, founder and chairman of the dynamically growing CDMO Inventys Research, highlights the crucial…
VS Reddy, fondly known as ‘The Protein Man of India’ and founder and managing director of British Biologicals,…
Jonathan Hunt, CEO of Syngene International, one of the fastest-growing and leading contract research and…